Literature DB >> 22014148

Castleman's disease in childhood: report of three cases and review of the literature.

Piero Farruggia1, Antonino Trizzino, Nunzia Scibetta, Giovanni Cecchetto, Patrizia Guerrieri, Emanuele S G D'Amore, Paolo D'Angelo.   

Abstract

Castleman's disease (CD) is a rare, localized or generalized, lymphoproliferative disorder with a frequent mediastinal location, but possible in any lymph node or extra nodal site. It usually appears in young adults whilst it rarely occurs in childhood. There are only about 100 pediatric cases published, five of them in Italy. We report 3 cases of localized Castleman's disease, investigated in our Department in a 3 years period and reviewed the literature.

Entities:  

Mesh：

Year:  2011        PMID： 22014148      PMCID： PMC3219574          DOI： 10.1186/1824-7288-37-50

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN： 1720-8424            Impact factor:   2.638


  45 in total

1.  Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease.

Authors:  Mark Bower; Ophelia Veraitch; Richard Szydlo; Peter Charles; Peter Kelleher; Brian Gazzard; Mark Nelson; Justin Stebbing
Journal:  Blood       Date:  2009-02-17       Impact factor: 22.113

2.  [Thoracic manifestations of Castleman's disease].

Authors:  T Dégot; A -C Métivier; S Casnedi; M -P Chenard; R Kessler
Journal:  Rev Pneumol Clin       Date:  2009-04-01

3.  Multifocal Castleman disease in pediatrics: case report.

Authors:  Mariana Baserga; Melissa Rosin; Michael Schoen; Guy Young
Journal:  J Pediatr Hematol Oncol       Date:  2005-12       Impact factor: 1.289

Review 4.  Neoadjuvant radiotherapy of primary irresectable unicentric Castleman's disease: a case report and review of the literature.

Authors:  Iris A C de Vries; Marjolein M S van Acht; Thomas B J Demeyere; Marnix L M Lybeert; Jean-Paul de Zoete; Grard A P Nieuwenhuijzen
Journal:  Radiat Oncol       Date:  2010-02-02       Impact factor: 3.481

5.  The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.

Authors:  T Powles; J Stebbing; A Bazeos; E Hatzimichael; S Mandalia; M Nelson; B Gazzard; M Bower
Journal:  Ann Oncol       Date:  2009-01-29       Impact factor: 32.976

6.  [Local recurrence of Castleman disease].

Authors:  K Ohara; K Narita; H Ishikawa; Y Kobayashi; S Atsuta; Y Matsumura; H Murayama
Journal:  Kyobu Geka       Date:  2009-02

7.  Reversible cardiomyopathy associated with Multicentric Castleman disease: successful treatment with tocilizumab, an anti-interleukin 6 receptor antibody.

Authors:  Junya Kanda; Hiroshi Kawabata; Yuhei Yamaji; Tatsuo Ichinohe; Takayuki Ishikawa; Toshihiro Tamura; Yutaka Furukawa; Takeshi Kimura; Toru Kita; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

8.  IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report.

Authors:  Caroline Galeotti; Tu-Anh Tran; Stéphanie Franchi-Abella; Monique Fabre; Danièle Pariente; Isabelle Koné-Paut
Journal:  J Pediatr Hematol Oncol       Date:  2008-12       Impact factor: 1.289

Review 9.  HIV-associated multicentric Castleman disease.

Authors:  Eric Oksenhendler
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

10.  Castleman's disease of the chest wall.

Authors:  Hitoshi Ueda; Hidenori Kouso; Shuichi Tsukamoto
Journal:  J Thorac Oncol       Date:  2009-03       Impact factor: 15.609
View more
  9 in total

1.  Unicentric Castleman's disease: an uncommon cause of posterior mediastinal mass.

Authors:  Aliasghar Alavi; Mehrnaz Asadi Gharabaghi
Journal:  BMJ Case Rep       Date:  2013-06-11

Review 2.  [True thymic hyperplasia : Differential diagnosis of thymic mass lesions in neonates and children].

Authors:  C-A Weis; B Märkl; T Schuster; K Vollert; P Ströbel; A Marx
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

3.  Atypical presentation of multicentric Castleman disease in a pediatric patient: pleural and pericardial effusion.

Authors:  Alkim Oden Akman; Ozge Basaran; Derya Ozyoruk; Unsal Han; Tulin Sayli; Nilgun Cakar
Journal:  Eur J Pediatr       Date:  2015-11-27       Impact factor: 3.183

4.  Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.

Authors:  Jenna Sopfe; Ashley Endres; Kristen Campbell; Kari Hayes; Andrew T Trout; Xiayuan Liang; Robert Lorsbach; Maureen M O'Brien; Carrye R Cost
Journal:  Pediatr Blood Cancer       Date:  2019-01-24       Impact factor: 3.167

Review 5.  Comprehensive analysis of 225 Castleman's diseases in the oral maxillofacial and neck region: a rare disease revisited.

Authors:  Xiaotong He; Qiong Wang; Yaping Wu; Jiaan Hu; Dongmiao Wang; Bin Qi; Wei Zhang; Yanling Wang; Jie Cheng
Journal:  Clin Oral Investig       Date:  2017-10-04       Impact factor: 3.573

6.  Multicentric Castleman's Disease in a Child Revealed by Chronic Diarrhea.

Authors:  Sarra Benmiloud; Sana Chaouki; Samir Atmani; Moustapha Hida
Journal:  Case Rep Pediatr       Date:  2015-02-09

7.  Intrathoracic Castleman's disease: "An important clinical mimicker".

Authors:  Rajendra Prasad Takhar
Journal:  Lung India       Date:  2017 Mar-Apr

8.  Detection of a unicentric type of Castleman-like mass at the site of adrenal grand: A case report and review of literature.

Authors:  Jing Chen; Cheng Yang; Chao-Zhao Liang
Journal:  World J Clin Cases       Date:  2018-11-06       Impact factor: 1.337

9.  Storming the castle: A case report of multi-system dysregulation in a child with Castleman disease.

Authors:  Samantha J DeMarsh; Nicole E Kendel; Christine Bacha; Stacy P Ardoin; Samir Kahwash; Melissa J Rose
Journal:  Clin Case Rep       Date:  2022-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.